# Sources — Marcus Aurelius

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 6, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Cassius Dio, *Roman History*, epitome of Book 72 (71 in some editions), translated by Earnest Cary (Loeb Classical Library, 1927), on LacusCurtius. Supports that he was so frail in body that at first he could not endure the cold, ate very little and only at night, and took nothing by day but the drug called theriac, "not so much because he feared anything, as because his stomach and chest were in bad condition" (chapter 6); the speech Dio gives him after the revolt of Avidius Cassius, in which he calls himself "unable to take either food without pain or sleep without anxiety" (chapter 24); his death on the seventeenth of March, "not as a result of the disease from which he still suffered, but by the act of his physicians", as Dio says he was told (chapter 33); and his age of fifty-eight years, ten months and twenty-two days. The page gives no year for the revolt and does not name the place of death. https://penelope.uchicago.edu/Thayer/E/Roman/Texts/Cassius_Dio/72*.html
2. *Historia Augusta*, *The Life of Marcus Aurelius*, part 1 (Loeb Classical Library, 1921), on LacusCurtius. Supports his birth at Rome on the sixth day before the Kalends of May, in a villa on the Caelian Hill (1.5); that as a boy excessive study impaired his health (3.7); and the pestilence in which the dead were removed in carts and wagons and thousands died, many nobles among them (13.3 to 13.5). https://penelope.uchicago.edu/Thayer/E/Roman/Texts/Historia_Augusta/Marcus_Aurelius/1*.html
3. *Historia Augusta*, *The Life of Marcus Aurelius*, part 2, with the editor's notes (Loeb Classical Library, 1921), on LacusCurtius. Supports his last illness: eager to die, he refrained from food and drink and so aggravated the disease, sent his son away for fear he would catch it, and died on the seventh day (28); and the editor's note 184, which gives Sirmium (Tertullian) and Vindobona (Aurelius Victor) as the place of death, cites Dio's report of poisoning by the physicians, and says the plague theory is not well supported. https://penelope.uchicago.edu/Thayer/E/Roman/Texts/Historia_Augusta/Marcus_Aurelius/2*.html
4. Sellars J. "Marcus Aurelius (121–180 C.E.)." *Internet Encyclopedia of Philosophy*. Supports his birth in 121 and death in 180; education in rhetoric by Fronto; adoption by Antoninus Pius in 138; accession in 161 with Lucius Verus and sole rule from 169; much of his reign on campaign in central Europe; and the composition of the *Meditations* there, probably about 171 to 175. https://iep.utm.edu/marcus/
5. Marcus Aurelius, *The Meditations*, Book One, translated by George Long (The Internet Classics Archive, MIT). Supports his thanks that remedies were shown to him in dreams, "against bloodspitting and giddiness", and "that my body has held out so long in such a kind of life" (1.17), and the closing line "Among the Quadi at the Granua." https://classics.mit.edu/Antoninus/meditations.1.one.html
6. Marcus Aurelius, *The Meditations*, Book Two, translated by George Long. Supports the closing line "This in Carnuntum." https://classics.mit.edu/Antoninus/meditations.2.two.html
7. Karaberopoulos D, Karamanou M, Androutsos G. "The theriac in antiquity." *Lancet* 2012;379(9830):1942-1943 (PMID 22645742). Read in full. Supports that Galen became court physician to Marcus Aurelius and Lucius Verus and prepared his theriac at the court; that the basic formula contained viper's flesh, opium, honey, wine, cinnamon and more than 70 ingredients; and that Marcus Aurelius took it daily to protect against poisons and for his general health. https://pubmed.ncbi.nlm.nih.gov/22645742/
8. Nencini P. "The rules of drug taking: wine and poppy derivatives in the Ancient World. VIII. Lack of evidence of opium addiction." *Subst Use Misuse* 1997;32(11):1581-1586 (PMID 9336867). Abstract read: no explicit ancient description of opium dependence; the only two suspected cases are Marcus Aurelius and Ovid; the most parsimonious interpretation is the lack of a hedonic use. https://pubmed.ncbi.nlm.nih.gov/9336867/
9. Trancas B, Borja Santos N, Patrício LD. "[The use of opium in Roman society and the dependence of Princeps Marcus Aurelius]." *Acta Med Port* 2008;21(6):581-590 (PMID 19331792). English abstract read: no solid evidence of addiction in Roman society, except the putative case of Marcus Aurelius. https://pubmed.ncbi.nlm.nih.gov/19331792/
10. Africa TW. "The Opium Addiction of Marcus Aurelius." *Journal of the History of Ideas* 1961;22(1):97-102 (doi:10.2307/2707876). Only the bibliographic record (Crossref) was read; JSTOR refused automated access. Cited as context for CLM-0012, not as support for any detail of its argument. https://doi.org/10.2307/2707876
11. Sabbatani S, Fiorino S. "[The Antonine Plague and the decline of the Roman Empire]." *Infez Med* 2009;17(4):261-275 (PMID 20046111). English abstract read: the epidemic flared from 165 AD, was spread by the Parthian war and the wars against the Marcomanni, was witnessed by Galen, and is thought by many to have been smallpox, without paleopathological confirmation. https://pubmed.ncbi.nlm.nih.gov/20046111/
12. Lapham's Quarterly, "Take some opium and call me in the morning" (Miscellany). A magazine summary of Galen's account: the emperor disliked the drowsiness the drug caused and stopped it, could not sleep, and took it again. Used only for CLM-0011, graded possible. https://www.laphamsquarterly.org/intoxication/miscellany/take-some-opium-and-call-me-morning
13. The Open University (OpenLearn), *Health and wellbeing in the ancient world*, Week 3, section 3.4, "Ancient tonics: antidotes." Supports that Galen says Marcus Aurelius took theriac every day to keep in good health. https://www.open.edu/openlearn/mod/oucontent/view.php?id=65957&section=3.4
14. HISTMED Master Roster v3. Internal project source; not treated as independent corroboration.

## Clinical guidance

1. Gulati M, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. *Circulation* 2021;144(22):e368-e454 (PMID 34709879): structured risk assessment, and CT coronary angiography or stress testing for stable chest pain at intermediate risk. https://pubmed.ncbi.nlm.nih.gov/34709879/
2. Katz PO, et al. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. *Am J Gastroenterol* 2022;117(1):27-56 (PMID 34807007): objective testing for reflux in chest pain without heartburn after cardiac evaluation; eight weeks of a proton pump inhibitor taken before a meal for erosive esophagitis; trial of discontinuation or on-demand therapy for Los Angeles grade A or B; meal timing and head-of-bed elevation; repeat endoscopy not routinely needed for grade A or B. https://pubmed.ncbi.nlm.nih.gov/34807007/
3. Moayyedi P, et al. ACG and CAG Clinical Guideline: Management of Dyspepsia. *Am J Gastroenterol* 2017;112(7):988-1013 (PMID 28631728). https://pubmed.ncbi.nlm.nih.gov/28631728/
4. Chey WD, et al. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. *Am J Gastroenterol* 2024;119(9):1730-1753 (PMID 39626064). https://pubmed.ncbi.nlm.nih.gov/39626064/
5. Dowell D, et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022. *MMWR Recomm Rep* 2022;71(3):1-95 (PMID 36327391): weigh benefits and harms with the patient, avoid abrupt discontinuation or rapid reduction, offer naloxone, avoid benzodiazepines and other sedatives with opioids, check the prescription drug monitoring program, use urine drug testing as part of care, and reassess within one to four weeks of a change. https://pubmed.ncbi.nlm.nih.gov/36327391/
6. Edinger JD, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. *J Clin Sleep Med* 2021;17(2):255-262 (PMID 33164742). https://pubmed.ncbi.nlm.nih.gov/33164742/
7. Qaseem A, et al. Management of Chronic Insomnia Disorder in Adults (American College of Physicians, 2016; PMID 27136449): CBT-I as first-line treatment. https://pubmed.ncbi.nlm.nih.gov/27136449/
8. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), hyperlipidemia monograph (coronary calcium score where the statin decision is uncertain, lipoprotein(a) once in adulthood, PREVENT risk recalculated every four to six years) and ischemic heart disease monograph. The CMID has no reflux or insomnia monograph. https://patrickrutledge.github.io/topthirty/
9. CDC, "Preventing Spread of Respiratory Viruses When You're Sick" (fever-free and improving for 24 hours, then added precautions for five days) and "COVID-19 Treatment: Clinical Care for Outpatients" (nirmatrelvir with ritonavir for people at higher risk, with attention to drug interactions); IDSA Guidelines on the Treatment and Management of Patients with COVID-19. https://www.cdc.gov/respiratory-viruses/prevention/precautions-when-sick.html, https://www.cdc.gov/covid/hcp/clinical-care/outpatient-treatment.html, https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/
10. U.S. Preventive Services Task Force A and B recommendations and topic recommendations (depression 2023, unhealthy alcohol use 2018, statin use 2022, prediabetes and type 2 diabetes 2021, colorectal cancer 2021, prostate cancer 2018, hepatitis C 2020, HIV 2019); CDC hepatitis B screening (2023; PMID 36893044) and the Adult Immunization Schedule by Age; Medicare Preventive Services reference (Aether Forge, 2026). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations

## Editorial resolutions

- **Recent-death rule.** He died in 180 CE, so the rule does not apply. Claims are limited to what the fetched sources state. Claims about his opium use are marked sensitive.
- **How little is knowable (thin chart).** Everything known about his health comes from a few lines in Cassius Dio, a senator who knew him, from the much later and less reliable *Historia Augusta*, from his own *Meditations*, and from Galen's remarks as reported by modern authors. These describe a frail body, a stomach and chest "in bad condition", eating little and only at night, pain with food and poor sleep, blood-spitting and giddiness, and daily theriac. No ancient source names a disease in modern terms, and none of these complaints can be diagnosed from the descriptions. Claims resting on Dio and the *Meditations* are graded **D** where the text plainly reports them (probable or possible, since the texts are literary), the speech in Dio is graded possible because ancient historians composed such speeches themselves, and every explanation (the cause of the plague, opium dependence, the cause of death) is **R**. The history is not padded.
- **Calendar and dates (judgment call).** The sources give Roman (Julian) dates: born 26 April 121 and died 17 March 180. As in other records with Julian dates, the true-frame dates use the proleptic Gregorian calendar, in which the same days are 25 April 121 and 16 March 180 (the calendars differed by one day in the second century). The Julian dates are kept as alternatives. Historical years are written with four digits (0121, 0180), and the record gets a true-date variant because he was born after 1 CE. The synthetic date of birth is therefore April 25, 1973 (shift 1852 years).
- **Index age and dates.** The index visit on May 12, 2026 maps to 12 May 174 CE (proleptic Gregorian), when he was 53, within the years about 171 to 175 when, by the *Meditations* and the IEP, he was on campaign in central Europe. The sources do not fix where he was in that year, so the record says only "on the Danube frontier" and does not choose between Carnuntum and Sirmium. All visits (May 12 to August 25, 2026) map to 174 CE, before his death in 180.
- **Claims after the index date.** The speech after the revolt of Avidius Cassius (CLM-0007) is commonly dated to 175 CE, after the index date, although the cited translation gives no year. The record therefore links it only to a timeline event placed about 175 CE, so the intake documents do not show it, and anchors the modern sleep complaint to Galen's account of his sleeplessness instead (CLM-0011). His death (CLM-0013, CLM-0014) is likewise shown only after the index date.
- **Place and cause of death.** The sources disagree on the place: Tertullian gives Sirmium and Aurelius Victor Vindobona (Vienna), as reported in the Loeb editor's note; the record leaves it unresolved. The cause is unknown: Dio's report that the physicians hastened his death is hearsay from a hostile court atmosphere, and the *Historia Augusta* suggests a contagious illness; both are graded **R**, disputed.
- **Opium: no addiction diagnosis (judgment call).** That he took theriac daily and that it contained opium are documented (CLM-0009, CLM-0010). Galen's account of the drowsiness and the sleeplessness when the poppy juice was left out (CLM-0011) was read only in a magazine summary, so it is graded **D**, possible. Whether he was dependent on or addicted to opium is disputed (CLM-0012, **R**): Africa argued for it in 1961, and later reviews find no ancient description of opium dependence and favour medicinal use. The record attributes no opioid use disorder to him and codes none.
- **The modern remedy and its coding (judgment call).** The modern counterpart of the theriac is an unregulated compounded herbal paste containing opium, bought from an overseas supplier, of unknown strength. It is coded with the RxNorm ingredient opium (RxCUI 7676), because no clinical drug matches an unregulated product, with historical_remedy naming theriac. The record codes the use as F11.90 (opioid use, unspecified, uncomplicated) because the use is documented as linked to his constipation and possibly to slowed gastric emptying; he meets one DSM-5-TR criterion at intake (withdrawal-like restlessness and poor sleep when he stopped it, which counts because the opioid is not prescribed) and none at fifteen weeks, so opioid use disorder is not diagnosed. Because an F11 code is present, the record has a safety assessment, the 988 Suicide & Crisis Lifeline in the plan, and a safety review at every later visit; no suicidality is suggested.
- **No forced taper (judgment call).** Following the CDC 2022 principles, the clinicians review the remedy without judgment, offer naloxone, advise against alcohol and sedatives with it, check the prescription drug monitoring program, test urine with his consent, and leave every change to him. He chooses to reduce to alternate nights at about three and a half weeks and to about two nights a week at eleven weeks, each reviewed within four weeks; the episode ends with the remedy continuing at his chosen level. Its start date, May 1, 2020 (about six years before the index visit), is synthetic.
- **Choosing the modern diagnosis (judgment call).** The presenting pattern (pain after meals, a single late meal, poor appetite and poor sleep) echoes Dio's description but implies no diagnosis of his real illness. A cardiac cause is excluded first: a normal ECG, no troponin because the pain is chronic without an acute episode, and CT coronary angiography rather than stress testing, because it excludes non-obstructive plaque and informs the cholesterol decision (calcium score 0). The endoscopy shows Los Angeles grade B esophagitis with a small hiatal hernia; peptic ulcer is excluded by the endoscopy, and functional dyspepsia is not diagnosed because a structural cause is found. Helicobacter pylori is negative. This differs on purpose from the panel's peptic ulcer record (a bleeding gastric ulcer with Helicobacter pylori): here the teaching is cardiac exclusion, reflux disease, the effects of opioids on the gut, and a respectful remedy review.
- **Presenting problem.** The pain after meals at intake is its own problem (R10.13), resolved at the endoscopy one week later, when K21.00 is recorded. The intake documents show only what was known then.
- **Lipids.** LDL 133 mg/dL with a coronary calcium score of 0, lipoprotein(a) 38 nmol/L and no other risk factor gives a low ten-year risk; no statin is advised, and risk is to be recalculated in four to six years, as the CMID hyperlipidemia monograph advises.
- **Setting and occupation.** The modern frame makes him the leader of a large public organization on a long field assignment far from home, the modern counterpart of an emperor on campaign; his evening writing echoes the *Meditations*. No military role is given in the modern record.
- **Sources not used.** Galen's *On Antidotes* was not read in a scholarly translation, and the Society for Classical Studies page that quotes it refused access. The letters between Marcus Aurelius and Fronto were found only on a site that labels its translations AI-assisted and not peer-reviewed, so nothing from them is claimed. Africa's 1961 article (JSTOR), a South African article on his illnesses and opium (Sabinet) and Britannica refused automated access; the De Imperatoribus Romanis entry could not be reached. The brief's mention of chronic chest and stomach pains and poor sleep "in his letters" is therefore supported here only by Dio and the *Meditations*.
- **Real people.** Antoninus Pius, Lucius Verus, Fronto, Galen, Commodus, Avidius Cassius, Cassius Dio, Tertullian, Aurelius Victor and the modern authors appear only in claims and sources. Galen is named only in documented history. No modern decision, statement or health fact is attributed to any of them; his children appear only as "has children". No family medical history is documented in the fetched sources, so the family history is left empty.
- **Name.** The display name is Marcus Aurelius, split simply into given and family names, so no name_parts are recorded. The alias "Marcus Aurelius Antoninus" appears in no other record. The notes call him Mr. Aurelius.
- **Synthetic content.** All visits, laboratory values, vital signs, the ECG, the CT coronary angiogram, endoscopic and histology findings, the urine drug test, survey scores, the Insomnia Severity Index (given in note text, since LOINC has no code for it), medicines and doses, the remedy and its amounts, his height (172 cm) and weights, his work and habits, and the health care agent are synthetic. Qualitative results (rapid urease test, histology, urine drug test, SARS-CoV-2 antigen test, HIV and hepatitis tests) appear only in the note text.
- **Sick visit.** Mild COVID-19 in July, chosen because it is a common modern infection that tests the remedy plan: no codeine or dextromethorphan cough medicine or sedating antihistamine with an opioid, no larger dose during illness, naloxone at hand, and a shared decision on nirmatrelvir with ritonavir, which he declines (age over 50 is a risk factor; ritonavir's interactions with an opium paste of unknown strength are hard to predict). It echoes the epidemic of his reign but is not a claim about the Antonine Plague or about any illness in his lifetime.
- **Preventive visit.** A periodic adult preventive visit at 53 (CPT 99396 with 99497 in plain text). Judgment calls: PCV20 at 50 or older; the first recombinant zoster dose; hepatitis B vaccination and HIV, hepatitis B and C screening; colonoscopy ordered with extra bowel preparation because opioids slow the bowel; prostate screening discussed from 55; the COVID-19 vaccine due about three months after the infection; advance care planning limited to his own general preferences.
- **Focused visits.** The three chronic-care follow-ups (one week with the CT coronary angiogram, endoscopy and consultation; five weeks; fifteen weeks) are documented as focused visits on the ACG 2022 reflux guideline, the ACG 2024 Helicobacter pylori and 2017 dyspepsia guidelines, the 2021 chest pain guideline, the CDC 2022 opioid guideline, the AASM 2021 and ACP 2016 insomnia guidance, the USPSTF depression recommendation and the CMID hyperlipidemia monograph. One deviation is recorded instead of an invented result: the first CBT-I session, due in the first week, could not be booked and began about three weeks after intake; no harm was judged likely, and the sleep clinician then held a weekly slot. No other protocol item was missed.
- **Consultation.** The gastroenterology referral and the consultation by Felix Brandt-Oyelaran, MD (a fictional consultant), on the day of the one-week visit, are **S**. The consultant answers the five referral questions in line with what the record shows afterwards: grade B reflux esophagitis with a small hiatal hernia, peptic ulcer excluded and functional dyspepsia not diagnosed; Helicobacter pylori negative (confirmed by histology at five weeks); omeprazole for eight weeks, then on demand; no repeat endoscopy, and manometry and reflux monitoring only if symptoms persist; the opioid's effect on the gut explained, with any change in the remedy left to the patient.
